Digital pest control: Bayern Kapital and Born2Grow participate in seed financing round of traplinked
Bayern Kapital, one of the most active and experienced investors in Germany’s high-tech financing market, and seed fund…
Bayern Kapital, one of the most active and experienced investors in Germany’s high-tech financing market, and seed fund…
SIRION Biotech GmbH is proud to announce our achievement of ISO 9001:2015 certification by DEKRA. ISO 9001 is the world…
SIRION Biotech, the leading German viral vector company, will present a Webinar on November 17 at 2 PM GMT discussing op…
The French Ministry of Higher Education, Research and Innovation have granted SIRION Biotech a 3-year CIR (Crédit Impôt…
SanoLiBio GmbH, a leading player in liquid biopsy innovation, announced today the nomination of its advisory board: Memb…
Cambridge based CYTO Consulting (“CYTO”) has helped SIRION Biotech GmbH (“SIRION”) opening its second foreign site outsi…
SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced…
A recent collaboration between Associate Professor Peter Johannes Holst at University of Copenhagen, his research group…
The viral vector specialist SIRION Biotech GmbH today announces the signing of a preferred partnership agreement with He…
SIRION Biotech GmbH and Vibalogics GmbH, have signed a strategic partnership agreement designed to meet demand from gene…